GenTarGet is a biopharmaceutical research and development company that develops the clinical application of first-in-class biomedicine.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Feb 6, 2018 | Series A | ¥10M | 3 | — | — | Detail |
Oct 19, 2015 | Angel | ¥3M | 3 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Shenzhen Fuli Shengshi Technology | — | Series A |
Shenzhenshi Maitian Touzi Youxian Zeren Gongsi | — | Series A |
Shenzhen Huasheng Carbon Biotechnology | — | Series A |
Shenzhen Hechuan Technology | — | Angel |
Maizhelun Ziben | — | Angel |
Shenzhen Wenbo Investment | — | Angel |